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The PKR protein kinase is an important regulator of viral mRNA translation. A ;50-kb gene (Pkr) encodes the human
PKR protein that is inducible by interferon (IFN). The Pkr promoter region has a novel 15-bp DNA element designated
as KCS required for transcriptional activity that is located 4 bp upstream of a 13-bp IFN-stimulated response element
(ISRE) that confers inducibility by type I IFN. We have carried out a systematic analysis of the 59 flanking region of the
human Pkr gene to define how the novel KCS element acts to affect basal as well as IFN-inducible transcription.
Electrophoretic mobility shift analyses (EMSA) revealed that nuclear proteins bound selectively to the KCS element in
a manner that was not dependent upon either IFN treatment or protein binding at the adjacent ISRE element. KCS
protein binding activity in vitro correlated with activation of transcription in vivo in transient transfection assays.
Competition and supershift EMSA assays revealed that multiple proteins were involved in bandshift complex formation
with KCS, one of which was identified as factor Sp1. In addition to the positive regulatory domain containing the KCS
and ISRE elements, a negative regulatory domain (NRD) was identified within a 40-bp region positioned ;400-bp
upstream of the KCS and ISRE elements. Deletion and substitution mutations indicated that the NRD negatively affected
Pkr transcription by a mechanism dependent upon the KCS element. These results define novel positive and negative
regulatory domains within the Pkr promoter that function through the KCS element to affect basal and IFN-inducible
transcription of Pkr. © 1999 Academic Press
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eINTRODUCTION
The RNA-dependent protein kinase (PKR)3 is an inter-
eron-inducible, cyclic AMP-independent protein serine/
hreonine kinase (Samuel, 1979, 1993; Sen and Lengyel,
992; Clemens and Elia, 1997). PKR plays a central role in
he regulation of protein synthesis in virus-infected and
FN-treated cells (Samuel, 1991; Clemens and Elia, 1997).
hosphorylation of the a subunit of eukaryotic protein
ynthesis initiation factor 2 on serine residue 51, a mod-
fication catalyzed by PKR (Samuel, 1993), leads to the
nhibition of mRNA translation (Hershey, 1989). PKR is
lso involved in the modulation of cytokine signaling and
ranscriptional activation via the NF-kB and STAT factors
The sequences reported in this study have been deposited in the
enBank database. The accession number assigned to 59-flanking
enomic sequence of the human Pkr gene, including the promoter
egion, is U51035.
1 Present address: School of Medicine, University of California, San
iego, La Jolla, CA 92093-0665.
2 To whom reprint requests should be addressed. Fax: (805) 893-
724.
3 Abbreviations: dsRNA, double-stranded RNA; eIF-2a, alpha subunit
f protein synthesis initiation factor 2; EMSA, electrophoretic mobility
hift assay; IFN, interferon; PKR, IFN-induced RNA-dependent proteinainase; Pkr, gene encoding the PKR kinase.
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182Kumar et al., 1997; Wong et al., 1997). Because of these
aried and fundamental biochemical activities, PKR af-
ects a range of biological processes. For example, PKR
s implicated in the control of cell growth, differentiation,
nd death (Lengyel, 1993; Clemens and Elia, 1997) as
ell as the antiviral actions of IFN (Samuel, 1991). Ex-
ression of the Pkr gene and activation of the PKR
nzyme are regulated in many different ways in animal
ells. These regulatory strategies include the transcrip-
ional induction of Pkr gene expression by IFN treatment
Meurs et al., 1990; Thomis et al., 1992; Tanaka and
amuel, 1994; Kuhen and Samuel, 1997), the translational
nhibition of PKR protein synthesis by an autoregulatory
echanism (Thomis and Samuel, 1992; Barber et al.,
993), posttranslational activation of PKR kinase activity
y an RNA-dependent autophosphorylation (Samuel,
979; Thomis and Samuel, 1993; Romano et al., 1998),
nd posttranslational modulation of PKR activity via ho-
omeric and heteromeric protein–protein interactions
Lee et al., 1994; Cosentino et al., 1995; Ortega et al.,
996; Patel et al., 1996; Benkirane et al., 1997).
The occurrence of increased transcription of the Pkr
ene in IFN-treated cells above the basal level of
xpression is firmly established from Northern gel blot
nd nuclear run-on analyses with human PKR cDNA
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183HUMAN Pkr PROMOTERrobes (Meurs et al., 1990; Thomis et al., 1992) as well
s transient transfection analyses with isolated pro-
oters from the human and mouse Pkr genes (Tanaka
nd Samuel, 1994; Kuhen and Samuel, 1997; Kuhen et
l., 1998). The human gene encoding the PKR kinase
pans ;50-kb on chromosome 2p with the mature
ranscript consisting of 17 exons, which encode a
51-amino acid protein (Kuhen et al., 1996). Transient
ransfection analyses using reporter plasmid construc-
ions possessing various 59 flanking fragments of the
uman Pkr gene led to the identification of a functional
ATA-less promoter that directs IFN-inducible tran-
cription (Kuhen and Samuel, 1997). Two DNA ele-
ents required for optimal promoter activity were
dentified. One was a consensus and functional copy
f the IFN-stimulated response element (ISRE) respon-
ible for the inducibility of many different genes by
ype I IFNs (Darnell, 1997; Nguyen et al., 1997). The
ther was a novel 15-bp element, which was required
or both basal and IFN-inducible promoter activity (Ku-
en and Samuel, 1997; Kuhen et al., 1998). This second
lement, designated as KCS for kinase conserved se-
uence, is exactly conserved in sequence (59 GG-
AAGGCGGAGTCC 39) between the human and
ouse Pkr promoters and in position relative to the
SRE element (Tanaka and Samuel, 1994; Kuhen and
amuel, 1997). The KCS element is found 4 bp imme-
iately upstream of the ISRE element in the Pkr pro-
oters.
It is well established that STATs (Darnell, 1997) and
RFs (Nguyen et al., 1997) activate transcription through
he ISRE element. However, no information is yet avail-
ble regarding how the novel KCS element functions to
ctivate transcription of the Pkr gene. Now it is important
o determine whether proteins bind selectively to the
CS element and, if so, whether the KCS protein binding
ctivity is affected by IFN treatment or by proteins bound
t the adjacent ISRE element. Additionally, it is important
o establish whether the activity of the KCS element is
odulated by regulatory elements present within flank-
ng sequences in a manner independent of the ISRE
lement.
Because of the central role of PKR in the antiviral
ctions of interferons (Samuel, 1991; Vilcek and Sen,
996) and the implicated roles of PKR in the control of
ell growth and differentiation as well as apoptosis
Lengyel, 1993; Clemens and Elia, 1997), we have
ttempted to define the cis-acting sequences and
rans-acting factors responsible for transcriptional
ontrol of the Pkr gene through the novel KCS element.
n this communication, we describe the functional
haracterization of positive and negative regulatory
omains within 59 flanking sequences of the human
kr gene that modulate basal and IFN-inducible pro-
oter activity. TRESULTS
eletion of the KCS element reduces Pkr promoter
ctivity
To examine whether elements reside in upstream
lanking sequences of the Pkr promoter that modulate
CS function, a series of 59 deletion mutants were gen-
rated that either lacked or retained the KCS element
Fig. 1). The 39 terminus of all the promoter constructs
erminated at the SacII site, 25 bp downstream of the
SRE element. The variable 59 ends extended through 1.6
b of upstream sequence (Fig. 1A). CAT reporter results,
alculated as the average from at least three indepen-
ent transient transfection experiments, are shown in
ig. 1B.
Comparison of pairs of Pkr promoter constructs, differing
nly in the presence or absence of the KCS element but
therwise equivalent, revealed that the KCS element en-
anced both basal and IFN-inducible transcription (Fig. 1B).
he enhanced transcription observed with constructs that
ncluded the KCS element was independent of the nature of
he 59 flanking sequences upstream of the KCS. Deletion of
he KCS motif reduced the Pkr promoter activity of all mem-
ers of the family of constructs that possessed increasing
mounts of genomic 59 flanking sequence upstream of
CS. These constructs varied from having no additional 59
equence in the case of the 63-bp P/Sa construct to ;1.5 kb
f added 59 sequence in the case of the 1.6-kb H/Sa con-
truct (Fig. 1). Basal CAT activity was reduced from 3- to
0-fold for the family of KCS del constructs and approached
ackground levels of activity. Activities in IFN-treated cells
ere likewise reduced in a comparable manner by deletion
f the KCS element, from three- to sevenfold relative to the
ild-type value, depending upon the 59 flanking sequence
resent. As a negative control, the promoterless pCAT-
asic plasmid vector without inserted genomic DNA exhib-
ted low CAT activity (,2% conversion). By contrast, the
ositive control plasmid pCAT-Control, which contains the
imian virus 40 promoter and enhancer, displayed high CAT
ctivity levels (.90% conversion) in the transient transfec-
ion assay. Neither pCAT plasmid vector, the promoter-less
CAT-Basic, or the SV40 pCAT-Control, showed IFN-induc-
bility of the CAT reporter (data not shown). These results
uggest that optimal transcriptional activation of the human
kr promoter requires the KCS element, both in untreated
nd IFN-a-treated human U cells. The combined presence
f the ISRE and upstream sequences containing potential
inding sites for positively acting factors including AP-1,
P-2, and Sp1 (Kuhen and Samuel, 1997) was unable to
ompensate for the loss of KCS function.
egulation of KCS element function by upstream
equences
We earlier observed that the KCS substitution mutant
M, possessing the three nucleotide substitutions (C8A,
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184 KUHEN AND SAMUEL9C, and G10T) within the KCS element, displayed
reatly reduced promoter activity when examined in the
ackground of the 503-bp Sa/Sa construct relative to the
nalogous wild-type 503-bp Sa/Sa construct (Kuhen and
amuel, 1997). We now have engineered the KCS sub-
FIG. 1. Deletion of the KCS motif reduces Pkr promoter activity indep
orresponds to the 59 region of the human Pkr gene and includes th
ranslation initiation site (ATG) for PKR is present in exon 3. The most 5
n an expanded format by the detailed lower restriction map that corr
chematic representation of the CAT reporter plasmids constructed by t
nto the promoterless pCAT-Basic plasmid. The KCS motif is depicted by
atched rectangle corresponds the ISRE element. The right side show
he indicated wild-type and KCS del mutant reporter plasmids. Promoter
f [14C]chloramphenicol to the acetylated derivatives. To control for tra
s an internal reference. Open bars refer to cells left untreated, and hatc
ene linked to the simian virus 40 promoter and enhancer; pCAT-Bas
ontaining the Pkr promoter.titution mutant TM into the same family of 59 deletion tonstructs (Fig. 2) as those examined with the KCS de-
etion (Fig. 1). Surprisingly, the mutant phenotype of the
CS triple substitution mutant TM was dependent upon
he length of the 59 flanking genomic sequence upstream
f the KCS element (Fig. 2). Those promoter constructs
of the upstream 59-flanking sequences. (A) The upper restriction map
lete 59 untranslated region present in exons 1, 2, and part of 3. The
of the upper map, including the promoter region and exon 1, is shown
s to the 1.72-kb HindIII/PstI promoter fragment. (B) The left side is a
rtion of the indicated human Pkr promoter region restriction fragments
lid oval; deletion of the KCS motif is depicted by the dashed lines. The
romoter activities observed in human amnion U cells transfected with
s of the various constructs are shown as percentage of the conversion
on efficiency, cells were cotransfected with the pRSV2-bgal construct
rs refer to cells treated with interferon. pCAT-Control, the CAT reporter
promoterless plasmid vector without inserted human genomic DNAendent
e comp
9 part
espond
he inse
the so
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nsfecti
hed ba
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185HUMAN Pkr PROMOTERf the SmaI site (503-bp Sa/Sa, 540-bp Stu/Sa, 1.3-kb
/Sa, and 1.6-kb H/Sa) showed a significant and consis-
ent repression of transcription, both in the absence and
resence of IFN treatment. Transcriptional repression
anged from a seven- to ninefold reduction measured by
AT reporter activity for the KCS sub mutant TM con-
tructs in cells treated with IFN-a (Fig.2), relative to
nalogous wild-type KCS promoter constructs (Fig. 1).
elative basal CAT activity levels were reduced ;15-fold
nd approached the background value of the pCAT-basic
onstruct (Fig. 2). A partial derepression of the negative
ffect that the KCS triple substitution mutation had on Pkr
romoter activity was observed when the 59 flanking
pstream sequence terminated at or downstream of the
maI site, as illustrated by the 252-bp Sm/Sa, 130-bp
/Sa, and 63-bp P/Sa constructs. Both basal and cyto-
ine-induced levels of CAT activity were similarly af-
ected. These results suggest that KCS function is regu-
ated, at least in part, by elements present in the up-
tream flanking sequences.
To ascertain if the negative regulatory effect exerted
y 59 flanking sequences upstream of the KCS was
pecific for the KCS element or whether the upstream
FIG. 2. Upstream 59 flanking sequences regulate transcriptional acti
s a schematic representation of the CAT reporter plasmids construc
ragments into the promoterless pCAT-Basic plasmid. The KCS elemen
he solid oval; the hatched rectangle denotes the WT ISRE element. The
atched rectangle. The solid oval depicts the WT KCS motif. The rig
ransfected with the indicated KCS sub mutant reporter plasmids. Prom
f [14C]chloramphenicol to the acetylated derivatives. To control for tra
s an internal reference. Open bars refer to cells left untreated, and ha
s described under the legend for Fig. 1.equences also affected transcriptional events mediated wy the ISRE element, the ISRE substitution G8T mutant
as examined in the same family of constructs that
ossessed variable amounts of 59 flanking sequence
pstream of the KCS motif. The results revealed that the
9 flanking sequences upstream of the KCS did not sig-
ificantly affect ISRE element function (data not shown).
he ISRE sub mutant displayed low activity with a wild-
ype KCS, independent of the length of 59 flanking se-
uence upstream of the KCS motif. The IFN-inducible
romoter activities of the KCS sub TM mutant and an
SRE sub G8T mutant were comparable and low in the
03-bp Sa/Sa promoter background, relative to the wild-
ype 503-bp Sa/Sa construct (Fig. 2).
ocalization of an upstream KCS-specific regulatory
egion
Because the analysis of the nested 59 deletion mu-
ants indicated that sequences upstream of the SmaI site
ffected the function of the KCS element (Fig. 2), internal
eletion mutants were generated in this region (Fig. 3).
hen the internal 210-bp EcoO109I(59) through SmaI
egion from the 503-bp Sa/Sa parent promoter construct
diated by the KCS element but not by the ISRE element. The left side
the insertion of the indicated human Pkr promoter region restriction
itution mutant TM (C8A, G9C, G10T) is depicted by the asterisk above
element substitution mutant G8T is depicted by the asterisk above the
shows the promoter activities observed in human amnion U cells
ctivities of the constructs are shown as percentage of the conversion
on efficiency, cells were cotransfected with the pRSV2-bgal construct
bars refer to cells treated with IFN. pCAT-Control and pCAT-Basic arevity me
ted by
t subst
ISRE
ht side
oter a
nsfecti
tchedas removed, a partial derepression of the negative
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186 KUHEN AND SAMUELffect observed with the KCS substitution mutant was
bserved. Deletion of only the 40-bp EcoO109I-EcoO109I
ragment from the 503-bp Sa/Sa parent construct gave
esults similar to those observed with the larger
coO109I-SmaI deletion. Both the constitutive and the
FN-a-inducible CAT activity levels were higher in cells
ransfected with KCS mutant constructs that lacked the
coO109I-EcoO109I fragment region. Interestingly, wild-
ype promoter activity was also increased by removal of
he EcoO109I fragment region from the reporter con-
tructs. These results suggest this region of the Pkr
romoter possesses negative regulatory element(s) that
ct to silence Pkr promoter function by modulating tran-
criptional events dependent upon the KCS motif.
roteins selectively bind the KCS element
Results of transient transfection analyses of the Pkr
romoter constructs suggest that the KCS element func-
ions as a positive regulatory domain (Figs. 1–3). The
ata are consistent with the role of KCS as a constitutive
ctivator element and that KCS is not involved in medi-
ting IFN inducibility. To examine whether protein factors
re present in human cells that bind selectively to the
CS element, EMSA analyses were conducted. A wild-
ype KCS synthetic oligomer was used as the probe.
hen incubated with nuclear extracts prepared from
ntreated human U cells, the 32P-labeled KCS probe
FIG. 3. Localization of a KCS-specific negative regulatory domain.
romoter constructs derived from the 503 bp Sa/Sa Pkr promoter fragm
otif is depicted by the solid oval; the KCS substitution mutant TM (C8
ectangle denotes the WT ISRE element. The right side shows the promo
03 bp Sa/Sa PKR promoter CAT reporter plasmids. Activities of de
onversion of [14C]chloramphenicol to the acetylated derivatives. To co
onstruct as an internal reference. Open bars refer to cells left untreat
CAT-Basic are as described under the legend for Fig. 1.ave two major complexes designated KBP for KCS bind- wng protein complex, and NS for nonspecific complex
Fig. 4). A third bandshift complex of minor intensity, with
relative intermediate mobility between KBP and NS,
as also detected (KBP9). Formation of the KBP com-
lexes was not dependent on IFN treatment (data not
hown; see also Fig. 7).
Specificity of protein binding to the KCS probe was
emonstrated by competition analysis. A 100-fold molar
xcess of unlabeled KCS oligo efficiently competed for
actor binding to the 32P-labeled KCS oligo probe (Fig. 4,
ane 3). By contrast, a 250-fold molar excess of the
nlabeled ISRE oligo did not significantly reduce the
mount of the KBP complex formed with the KCS oligo
robe (Fig. 4, lane 8). The formation of the faster migrat-
ng NS bandshift complex was competed comparably by
100-fold molar excess of either the KCS or the ISRE
ligo, suggesting a nonspecific (NS) DNA-binding activ-
ty. These results demonstrate that nuclear proteins can
electively bind the KCS element in vitro.
CS protein binding in vitro correlates with
ranscriptional activation in vivo
To examine whether the formation of the KBP band-
hift complex in vitro correlates with KCS-mediated tran-
criptional activity in vivo in the transient transfection
ssay, two KCS single bp substitution mutants were
enerated, and their activities compared to that of the
chematic representation (left side) summarizes the deletion mutant
serted into the promoterless pCAT-Basic plasmid vector. The WT KCS
, G10T) is depicted by the asterisk above the solid oval. The hatched
vities observed in human amnion U cells transfected with the indicated
onstructs, both WT and KCS sub, are shown as percentage of the
r transfection efficiency, cells were cotransfected with the pRSV2-bgal
hatched bars refer to cells treated with interferon. pCAT-Control andThe s
ent in
A, G9C
ter acti
letion c
ntrol fo
ed, andild-type KCS in transient transfections and EMSA as-
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187HUMAN Pkr PROMOTERays. For analysis of transcriptional activity, the two sin-
le bp KCS substitution mutants, KCS(mt6A) and
CS(mt9T), were introduced into the background of the
03-bp Sa/Sa PKR promoter CAT reporter construct. The
romoter activities of the resultant KCS(mt6A) and
CS(mt9T) constructs were substantially reduced rela-
ive to the wild-type parent 503-bp Sa/Sa construct (Fig.
). The activities, both basal and IFN-inducible, of the
CS(mt6A) and KCS(mt9T) mutants were low, and com-
arable to that of the 503-bp Sa/Sa TM mutant construct
Fig. 5). These data further support the notion that the
CS element has a positive regulatory role in the tran-
cription of the Pkr gene.
The ability of double-stranded KCS(mt6A) and
CS(mt9T) mutant oligomers to compete the formation of
he KBP complex formation was examined at varying
ligomer concentrations, ranging from a 5- to 100-fold
olar excess of the unlabeled competitor over the 32P-
FIG. 4. Detection of KCS-binding proteins by electrophoretic mobility
hift assay (EMSA). KCS complexes were detected in nuclear extracts
repared from human amnion U cells. EMSA was carried out using a
ynthetic dsDNA oligomer probe, possessing the KCS element, that
orresponded to nt 614–637 of the human Pkr promoter. Nuclear ex-
racts (9 mg of protein) were incubated with 32P-labeled KCS oligomer
robe in the absence of competitors (lanes 2 and 6) or presence of
ither a 100- or 250-fold molar excess of the unlabeled wild-type 24-mer
CS oligomer (lanes 3 and 4) or wild-type 23-mer ISRE oligomer (lanes
and 8). The KCS-binding protein complexes (KBP, KBP9) are indicated
s well as the unbound free probe. NS, nonspecific binding.abeled KCS(WT) probe. As shown in Fig. 6, the KCS(mt6A) oligo had no apparent competitive effect on
BP complex formation, whereas KCS(mt9T) interestingly
as a weak competitor when examined at high molar
xcess. The data point which corresponds to a 100-fold
olar excess of unlabeled competitor represents an av-
rage of six experiments (Fig. 6). Typically, ;55% of the
CS-specific KBP bandshift complex remained even
FIG. 5. Single nucleotide substitutions within the KCS element re-
uce Pkr promoter activity. Mutant promoter constructs were derived
rom the 503-bp Sa/Sa wild-type parent plasmid. KCS(WT), the 15-bp
ild-type KCS element in the 503-bp Sa/Sa construct. For KCS(mt6A)
nd KCS(mt9T), the indicated G6 to A6, or G9 to T9, substitution was
ntroduced within the KCS motif. KCS(TM), the triple substitution KCS
utant (C8A, G9C, G10T). Promoter activities of the constructs are
hown as percentage of the conversion of [14C]chloramphenicol to the
cetylated derivatives. To control for transfection efficiency, cells were
otransfected with the pRSV2-bgal construct as an internal reference.
pen bars refer to cells left untreated, and hatched bars refer to cells
reated with interferon. pCAT-Control and pCAT-Basic are as described
nder the legend for Fig. 1.
FIG. 6. Effect of competitor oligonucleotide concentration on KBP
omplex formation measured by EMSA. Nuclear extract prepared from
uman amnion U cells was incubated with 32P-labeled KCS(WT) oligo-
ucleotide probe, either in the absence of competitors or presence of
he indicated concentration of unlabeled competitor as follows:
CS(WT), KCS(mt6A) mutant, or KCS(mt9T) mutant. A Bio-Rad GS525
olecular imager system was used for quantification of the amount ofBP complex formed.
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188 KUHEN AND SAMUELhen a 100-fold molar excess of the KCS(mt9T) oligomer
as added. By comparison, the KCS(mt6A) oligomer did
ot compete the binding of the 32P-labeled KCS(WT)
robe. The wild-type KCS oligomer was an efficient com-
etitor; a 100-fold molar excess of KCS(WT) completely
revented bandshift formation (Fig. 6). These results in-
icate that KBP complex formation detected by EMSA
orrelates with transcriptional activation measured by
ransient transfection of a CAT reporter, and that more
han one protein component may be responsible for
ediating KCS function.
The 130-bp BamHI/SacII fragment from the 59 flanking
egion, which possesses both the KCS and ISRE regula-
ory elements, supported CAT gene transcription in an
FN-inducible manner (Fig. 1). When this 130-bp natural
romoter fragment was examined as the probe in the
MSA assay, a bandshift complex was detected (Fig. 7)
FIG. 7. Effect of interferon treatment on KCS-binding protein complex
ormation detected by EMSA. EMSA was carried out with the 130-bp
/Sa DNA fragment that possesses both the KCS and ISRE elements.
uclear extracts prepared from human amnion U cells (9 mg of protein),
ither untreated or treated with IFN-a, were incubated with the 32P-
abeled 130-bp B/Sa DNA fragment. IFN treatment ranged from 0 (lane
) to 24 h (lanes 3–6), as indicated. Specificity of binding to the fragment
as determined by competition (lanes 7–11), using extracts prepared
rom cells treated for 6 h with IFN-a. 32P-labeled BamHI/SacII probe
as examined in the absence of competitors (lanes 1–6) or presence
f a 100-fold molar excess of the indicated dsDNA synthetic oligomers
s indicated: KCS(WT) (lane 7), KCS(mt6A) mutant (lane 8), KCS(mt9T)
utant (lane 9), ISRE(WT) (lane 10), or KCS:ISRE(WT) (lane 11). KBP,
CS-binding protein complex.hat possessed characteristics comparable to those ob- ierved for the chemically synthesized KCS(WT) probe
Fig. 6). The major KBP bandshift complex observed with
he 32P-labeled BamHI/SacII probe was efficiently com-
eted, both with the KCS(WT) and the KCS:ISRE oli-
omers at 100-fold molar excess (Fig. 7, lanes 7 and 11,
espectively). However, the ISRE(WT) and the mutant
CS(mt6A) oligos did not compete (Fig.7, lanes 8 and 10)
nder similar conditions, and the KCS(mt9T) mutant oli-
omer was only a weak competitor (Fig. 7, lane 9). For-
ation of the KBP complex was comparable with nuclear
xtracts isolated from U cells that had been left untreated
s compared to cells treated with a saturating concen-
ration of IFN-a during a 24-h period (Fig. 7, lanes 2–6).
he 59 and 39 halves of the KCS element each
ediate transcription factor binding
The observation that the KCS(mt9T) oligomer partially
ompeted for protein binding to the wild-type KCS probe
n EMSA analysis (Figs. 6 and 7) suggested that the
CS(mt9T) oligo retained limited protein binding activity
ven though the substitution of a T for G at nt position 9
f the KCS element inhibited transcription measured with
he CAT reporter (Fig. 5). Indeed, when the KCS(mt9T)
utant oligo was used as the probe in the EMSA assay,
he 32P-labeled KCS(mt9T) oligomer possessed the abil-
ty to bind in a specific manner factors constitutively
resent in nuclear extracts from U cells (Fig. 8A). Forma-
ion of the 32P-labeled KCS(mt9T)-specific bandshift com-
lex, designated KBP1, was competed completely by a
00-fold molar excess of either wild-type KCS(WT) or
utant KCS(mt9T) unlabeled oligomer (Fig. 8A, lanes 3
nd 4). However, the mutant KCS(mt6A) and wild-type
SRE oligomers only partially competed complex forma-
ion with the KCS(mt9T) probe (Fig. 8A, lanes 5 and 6).
The finding that the 32P-labeled KCS(mt9T) probe gen-
rated a minor bandshift relative to the wild-type KCS
robe (Fig. 8A) suggested that a second KBP may pos-
ibly be involved in increasing the affinity of KBP1 for the
CS motif or alternatively that optimal binding by KBP1
ay require the wild-type sequence at both positions 6
nd 9 of the KCS motif. Therefore, the KCS(mt6A) oli-
omer was examined as the probe in an EMSA assay. As
hown in Fig. 8A, the KCS(mt6A) probe formed a com-
lex, designated herein as KCS-binding protein 2 or
BP2, that was competed by unlabeled KCS(WT), mutant
CS(mt6A), mutant KCS(mt9T), and ISRE(WT) oligomers
Fig. 8A, lanes 8–12). This result suggested either that
BP2 had a low affinity for KCS or that the KBP2 complex
as nonspecific.
he Sp1 transcription factor is likely involved in
ediating KCS function
The 59 portion of the KCS element corresponding to
he GGGAAGG sequence conforms to a low-affinity bind-
ng site for the Sp1 transcription factor (Kutoh et al.,
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189HUMAN Pkr PROMOTER993). To determine whether the Sp1 factor binds to the
CS motif and potentially is a component of KBP1, U cell
uclear extracts were examined for bandshift activity
ith 32P-labeled wild-type KCS probe in the presence of
human Spl monoclonal antibody added prior to addi-
ion of the probe. Addition of Sp1 antibody greatly re-
uced KBP complex formation with the wild-type KCS
ligo (Fig. 8B, lane 7). Longer autoradiogram exposure
imes revealed that a supershift complex was generated
KBPl*) when the Sp1 antibody was present (Fig. 8B, lane
7). Curiously, two bandshift complexes remain, desig-
ated KBP2 and KBP3. When U cell nuclear extracts
ere pre-incubated with the Spl antibody and then either
he KCS(mt6A) or the KCS(mt9T) 32P-labeled-probe was
dded, the Spl antibody abrogated KBP1 complex forma-
ion with the KCS(mt9T) probe (Fig. 8B, lane 14) but not
BP2 complex formation with the KCS(mt6A) probe (Fig.
B, lane 11). These results indicate that two or more
ifferent proteins are involved in selective complex for-
ation with the KCS element to generate complexes that
isplay a similar gel mobility under the assay conditions
mployed. The results also revealed the bandshift com-
lex generated with the KCS(mt6A) probe does not in-
olve Sp1 but rather likely represents a low-affinity KCS
FIG. 8. Multiple proteins bind selectively to the KCS element as dete
f protein) were incubated with either wild-type (WT) or mutant 32P-l
ndicated. (A) Probes were KCS(mt9T) (lanes 1–6) or KCS(mt6A) (lanes
econd KCS DNA binding protein, specific for KCS(mt6A). (B) KCS wild
robe (lanes 12–14), examined in the presence (lanes 7, 8, 11, and 14) or
omplexes are indicated. Lanes 15–17, EMSA assay carried out as fo
omplex (KBP1*).andshift. By contrast, the KCS(mt9T)-specific shift likely tncludes an Sp1-like transcription factor, consistent with
he retention of an intact Sp1 binding site within the
utant KCS(mt9T) oligomer.
ltered spacing between the KCS and ISRE elements
oes not affect Pkr promoter activity whereas
uplication of the elements enhances basal activity
Because of the close proximity of the KCS and ISRE
lements to each other and because the spacing of the
bp between the elements is exactly conserved be-
ween the human (Kuhen and Samuel, 1997) and the
ouse (Tanaka and Samuel, 1994) Pkr promoters, it is
onceivable that protein factors that bind to the two
lements may interact with each other. To begin to ad-
ress this possibility, the spacing between the two ad-
acent elements was increased by an increment of 4 bp.
ecause 10 bp comprise a full turn of a DNA helix and 5
p constitute a half-turn (Werner et al., 1996), it was
nticipated that an insertion of 4 bp might cause DNA-
inding proteins to no longer contact their cognate sites
n the same face of the helix. Thus the insertion might
lter the potential for protein–protein interactions. As
hown in Fig. 9, the increased spacing by 4 bp between
y EMSA. Nuclear extracts prepared from human amnion U cells (9 mg
KCS probe. Competitors were present at 100-fold molar excess as
KBP1, the single KCS binding protein specific for KCS(mt9T). KBP2, a
robe (lanes 1–8), the KCS(mt6A) probe (lanes 9–11), or the KCS(mt9T)
e of monoclonal antibody against Spl. The KBP1 (Spl), KBP2, and KBP3
1, 2, and 7, but the gel was overexposed to detect the supershiftedcted b
abeled
7–12).
-type p
absenc
r laneshe KCS and ISRE elements did not significantly affect
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190 KUHEN AND SAMUELkr promoter activity. The family of 59 nested deletion
onstructs possessing the insertion (ins) mutation dis-
layed activities comparable to the 503 Sa/Sa (wt) refer-
nce construct (Fig. 9). These results suggest that KCS-
nd ISRE-binding proteins and their cognate DNA-bind-
ng sites likely function in separate and distinct manners
o activate efficient transcription of the human Pkr gene.
The results shown in Fig. 1 revealed that the 63-bp
ragment of the 59 flanking region of the Pkr gene that
ossessed the KCS and ISRE elements displayed IFN-
nducible promoter activity in the transient transfection
AT reporter assay. As shown in Fig. 10, this activity was
ependent upon the presence of the KCS element be-
ause the 40-bp St/Sa construct that lacks the KCS
lement showed greatly reduced promoter activity rela-
ive to the 63-bp P/Sa construct. However, the chemically
ynthesized KCS:ISRE promoter designed to contain only
he KCS and ISRE elements, flanked by the native 59 and
n engineered 39 PstI restriction site, showed IFN-induc-
ble promoter activity. The IFN-inducible and the basal
romoter activities of the synthetic KCS:ISRE promoter
ere comparable to those of the natural 63-bp P/Sa
onstruct (Fig. 10). Surprisingly, the (KCS:ISRE)x2 con-
truct that possessed tandem copies of the synthetic
CS:ISRE DNA fragment showed very strong basal pro-
oter activity that was not significantly further increased
y IFN treatment (Fig. 10). The increase in basal pro-
FIG. 9. Increased spacing between the KCS and ISRE motifs doe
ummarizes the CAT reporter constructs that possess an increased spa
our nt ‘‘CAAG’’ at the StyI site between the two elements. The solid o
lement. The right side shows the promoter activities observed in hum
lasmids. Activities are shown as percentage of the conversion of [14
fficiency, cells were cotransfected with the pRSV2-bgal construct as a
efer to cells treated with interferon. pCAT-Control and pCAT-Basic areoter activity observed upon duplication of the KCS glement is consistent with the conclusion that KCS pos-
esses a constitutive activator function.
DISCUSSION
This investigation was undertaken to gain insight into
he mechanism by which the novel DNA element present
ithin the Pkr promoter, designated as KCS (Kuhen and
amuel, 1997), affects basal as well as IFN-inducible
ranscription of the RNA-dependent protein kinase PKR.
lthough PKR is an IFN-inducible enzyme that is part of
he antiviral response (Samuel, 1991), significant basal
xpression of PKR is often observed in human cells
Samuel, 1979; Thomis et al., 1992; Clemens and Elia,
997). Five important points emerged from our studies of
he 59 flanking region of the human Pkr gene that provide
ew insights regarding the manner in which the activity
f the Pkr promoter is controlled as well as the role of the
CS element in the modulation of Pkr promoter activity.
irst, the KCS element functions as a positive regulatory
lement that is required both for basal and for IFN-
nducible transcriptional activity of the human Pkr pro-
oter. Second, nuclear proteins selectively bind to the
CS element in a manner that is not dependent upon IFN
reatment. Third, KCS protein binding activity in vitro
orrelates with activation of transcription in vivo in a
ransient transfection assay. Fourth, the protein com-
lexes that interact with the KCS element can be distin-
ffect Pkr promoter activity. The schematic representation (left side)
etween the KCS element and the ISRE element by insertion (ins) of the
otes the WT KCS motif; the hatched rectangle denotes the WT ISRE
nion U cells transfected with the indicated Pkr promoter CAT reporter
ramphenicol to the acetylated derivatives. To control for transfection
al reference. Open bars refer to cells left untreated, and hatched bars
scribed under the legend for Fig. 1.s not a
cing b
val den
an am
C]chlo
n internuished by competition EMSA assays from those that
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191HUMAN Pkr PROMOTERnteract at the adjacent ISRE element. Three complexes
ormed with KCS, involving proteins designated KBP1,
BP2, and KBP3. KBP1 appears equivalent to the tran-
cription factor Sp1. Fifth, a negative regulatory domain
NRD) is present within a 40-bp region located ;400 bp
pstream of the KCS and ISRE elements. The NRD do-
ain negatively affects Pkr transcription by a mechanism
ependent upon the KCS element. The schematic dia-
ram shown in Fig. 11 provides a summary of the relative
rganization of the KCS, ISRE, and NRD DNA elements
ithin the promoter region of the human Pkr gene, and
he cognate trans-acting proteins bound by them.
The KCS element was specifically bound by proteins
resent in the nuclear extracts prepared from human
ells, designated as KBPs for KCS binding proteins. The
inding of KBP proteins to the KCS element measured by
MSA in vitro correlated with the activity of the promoter
n transfected cells measured with the CAT reporter.
ystematic mutational analysis of the 15-bp KCS element
ermitted the identification of the nucleotide positions
ithin the element that are most essential for transcrip-
ional activity. From the analysis of a total of 45 KCS
ingle substitution mutants in the background of the
arent 503 Sa/Sa promoter construct that contains the
ild-type ISRE element, it was found that substitutions at
ither position 6 or 9 greatly reduce promoter activity
Kuhen et al., 1998). Two 503 promoter mutants,
CS(mt6A), which possesses an A in place of the G at
osition 6, and KCS(mt9T), which possesses a T in place
FIG. 10. Promoter activity of chemically synthesized KCS and ISRE el
ummarizes the CAT reporter constructs that possess either the natura
he 59 flanking region of the Pkr gene, or a synthetic promoter fragem
chemically synthesized DNA fragment possessing only the KCS and
KCS:ISRE)x2 construct possesses tandem copies of the synthetic KCS:
escribed under the legend for Fig. 1.f the wild-type G at position 9, lacked appreciable pro- Ioter activity in human cells transiently transfected with
AT reporter constructs. The formation of specific KBP
andshift complexes were readily detectable by EMSA
ith the KCS(WT) element as the 32P-labeled oligonucle-
tide probe. Although such complex formation was effi-
iently competed with the unlabeled KCS(WT) oligomer,
in single and tandem copies. The schematic representation (left side)
rring 63-bp PstI-SacII fragment and the 40-bp StyI-SacII fragment from
erted into the pCAT-Basic vector. The KCS:ISRE construct consists of
elements flanked by the native 59 and engineered 39 PstI sites. The
gment inserted into pCAT-Basic. pCAT-Control and pCAT-Basic are as
FIG. 11. Schematic summary of the organization of the promoter
egion of the human Pkr gene. The upper restriction map corresponds
o the 59 flanking region of the human Pkr gene. The solid squares
orrespond to exons 1, 2, and part of 3. The translation initiation site
ATG) for PKR is present in exon 3. The most 59 part of the upper map
orresponding to the promoter region is shown in an expanded format
y the detailed lower schematic that depicts positive (KCS, ISRE) and
egative (NRD) regulatory elements. ISRE, the 13-bp IFN-stimulated
esponse element (ISRE) responsible for IFN inducibility to which STAT
nd IRF factors bind; KCS, the novel 15-bp element required for optimal
romoter activity to which Sp1 and as yet unidentified additional pro-
eins (KBP) bind; and NRD, the negative regulatory domain correspond-
ng to the 40-bp EcoO109I-EcoO109I fragment upstream of the KCS andements
lly occu
ent, ins
ISRE
ISRE fraSRE elements.
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192 KUHEN AND SAMUELt was not effectively competed with either the
CS(mt6A), the KCS(mt9T) or the ISRE(WT) oligomer
hen examined as the unlabeled competitor. Both the
asal and the IFN-inducible promoter activities of the
ingle substitution KCS promoter mutants KCS(mt6A) and
CS(mt9T) in the 503 promoter background were effec-
ively abolished, consistent with the impaired and re-
uced protein binding activity of the KCS(mt6A) and
CS(mt9T) mutant oligomers, respectively, revealed by
heir inability to compete in the EMSA assay (Fig. 6).
Our results obtained from the analysis of deletion and
ubstitution mutants suggest that the constitutive activa-
or function of the KCS element may be regulated by both
ctivator and repressor proteins. The NRD regulatory
egion, localized to a 40-bp sequence ;400 bp upstream
f KCS, was observed to exert a silencing effect on Pkr
ene transcription through involvement of the 59 half of
he KCS element. That transcriptional silencing is ob-
erved only in the presence of both the NRD region (Fig.
) and the KCS element and more specifically the 59 half
f the KCS (Fig. 2), it is conceivable that modulation of
CS function by the 40-bp NRD may involve a repressor
rotein that impairs the function of a KCS activator pro-
ein. This might occur indirectly by protein–protein inter-
ctions between the putative repressor protein bound at
he NRD and a KCS activator protein or directly by pro-
ein–DNA interactions involving a repressor bound at the
CS activator site but stabilized through NRD protein
nteractions. Interestingly, we have observed that two
CS substitution mutants (G2A and A5G) possess
lightly increased promoter activity, both basal and in-
ucible (Kuhen et al., 1998), which is consistent with
egative regulation of KCS function through the 59 half of
CS.
The Pkr promoter region is G/C rich and contains
otential Sp1 binding sites immediately 59 of the ISRE,
ncluding a consensus Sp1 site (GGGCGG) and also a
ow-affinity Sp1 site (GGGAAGG) that corresponds to the
9 half of the KCS element. Interestingly, a similar ar-
angement of the ISRE element and Sp1 sites occurs in
he IFN-inducible promoter of the 6–16 gene (Porter et al.,
988). The EMSA results obtained using KCS mutant
ligos KCS(mt6A) and KCS(mt9T), and a monoclonal an-
ibody to Sp1, are consistent with the notion that Sp1 is
quivalent to KBP1 and that the binding of the KCS
lement by the activator proteins KBP1 and KBP2 posi-
ively affects the constitutive level of Pkr gene expres-
ion. It is well established that Sp1 factors can stimulate
romoter-specific activation of RNA polymerase II tran-
cription by mechanisms involving cooperative interac-
ions with other transcription factors (Kadonaga et al.,
986; Kutoh et al., 1993). Interestingly, it has been re-
orted that Stat1 function depends on transcriptional
ynergy with Sp1 (Look et al., 1995).
Two important families of transcription regulators in-
olved in modulation of the transcriptional activity of pFN-inducible promoters through the ISRE element are
he STATs (Darnell, 1997) and IRFs (Nguyen et al., 1997).
FN treatment mediates phosphorylation of Stat1 and
tat2 in the cytoplasm and their subsequent heterodimer
ormation and nuclear translocation and transcriptional
ctivation via binding to the cis-acting ISRE element
Darnell, 1997). In the case of IFN-a, the multiprotein
ranscriptional activator complex ISGF3 composed of
tat1, Stat2, and p48 binds to the ISRE element. The ISRE
lement also binds members of the IFN regulatory factor
IRF) family of proteins to which the p48 DNA-binding
rotein component of the ISGF3 complex belongs
Nguyen et al., 1997). In addition to interaction of STATs
nd IRFs with the ISRE DNA element, the STAT and IRF
roteins also interact with other DNA-binding proteins
uch as Sp1, CBP, PU1, and p300 (Look et al., 1995;
arnell, 1997; Nguyen et al., 1997). Our results reveal that
wo additional DNA elements affect the ISRE-dependent
Kuhen and Samuel, 1997) transcription of the human Pkr
ene: the positively acting KCS element to which Sp1
nd perhaps two or more other proteins bind and the
pstream negatively acting NRD, which mediates its
unction in a manner dependent upon the KCS element.
he KCS element affects both basal and IFN-inducible
ranscription of the Pkr gene. However, because the ISRE
ligomer did not compete with the complex formation
enerated with the KCS probe detected by EMSA unless
he KCS element sequence was also present with the
SRE sequence in the competitor, it appears that protein
inding at the KCS element occurs independently of
roteins such as STATs and IRFs bound at the ISRE
lement.
It is now of utmost importance to attempt to identify the
BP2 and KBP3 protein factors that interact with the KCS
lement and to determine how these proteins function
ith Sp1 (KBP1) to affect the transcriptional activity of the
kr promoter through the KCS element. In addition, the
lucidation of the biochemical mechanism by which the
egative regulatory domain located upstream of the KCS
lement affects Pkr promoter activity, and whether the
ffects of NRD differ under varying conditions of cell
rowth and cytokine treatment, is of central importance.
MATERIALS AND METHODS
onstruction of reporter gene plasmids
The pCAT-Basic promoterless plasmid (Promega) con-
aining the chloramphenicol acetyltransferase (CAT)
ene was used for construction of the PKR promoter:CAT
eporter gene plasmids. The 503-bp Sa/Sa human PKR
romoter construct in the pCAT-Basic promoterless plas-
id, the single nucleotide substitution mutation within
he ISRE element (G8T) of the 503-bp Sa/Sa construct,
nd the triple substitution mutation within the KCS motif
C8A, G9C, G10T) of the 503-bp Sa/Sa construct were as
reviously described (Kuhen and Samuel, 1997). The two
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193HUMAN Pkr PROMOTERutant KCS PCR products, each possessing a single bp
ubstitution within the KCS element, were subcloned into
he 503-bp Sa/Sa promoter parent background by ex-
hanging the PstI (PKR)-XbaI (pCAT-MCS) region for the
stI-SacII-digested PCR product possessing the KCS
utation. The 503-bp Sa/Sa promoter constructs pos-
essing internal deletions were generated by removal of
he internal restriction fragment with the appropriate en-
onucleases, and then each was blunted and ligated
sing T4 DNA polymerase and T4 DNA ligase, respec-
ively. The promoter constructs that possessed the 4-bp
AAG insertion between the KCS and ISRE elements
ere generated by digestion of the indicated promoter
ragment in the pBluescript vector with StyI restriction
ndonuclease. pBluescript lacks vector StyI sites, unlike
he pCAT-Basic vector, which possesses two StyI sites.
he StyI overhangs of the linearized pBluescript-PKR
onstruct were then filled in using Klenow fragment poly-
erase to generate the insertion and then circularized
sing T4 DNA ligase. The insertion mutant promoter
ragments were subcloned from pBluescript into the
CAT-Basic promoterless plasmid for expression analy-
es. All subcloning procedures were carried out follow-
ng standard cloning procedures (Sambrook et al., 1989),
nd resultant constructs were confirmed by restriction
nzyme analysis and/or sequence analysis. Plasmid
ubclones were sequenced by the Sanger dideoxynucle-
tide procedure to verify the construction (Sanger et al.,
977).
ligonucleotide-directed mutagenesis
Single nucleotide substitutions within the KCS element
f the human Pkr 59 flanking region (Kuhen and Samuel,
997) were generated using a PCR-based method for
ite-directed mutagenesis. The PCR products were en-
ineered to possess appropriate restriction sites that
ould facilitate subcloning of the mutated KCS element
nto the 503-bp Sa/Sa human PKR promoter parent con-
truct. The PCR (1) primers were the oligonucleotides
sed for mutagenesis; primers possessed the 15-nt KCS
otif and the naturally occurring and partially overlap-
ing 59 flanking PstI restriction enzyme site, which is
ndicated in italic type: 59CTGCAGGGAAGGCGGA-
TCC39. The KCS(mt6A) mutant at position 6 was gen-
rated with an oligomer of the sequence 59CTGCAGG-
AAAGCGGAGTCC39 and the KCS(mt9T) with the oli-
omer 59CTGCAGGGAAGGCTGAGTCC39, where the un-
erlined bold type indicates the site of the nucleotide
ubstitution. The minus primer was the pCAT-Basic (2)
ligonucleotide 59CAACGGTGGTATATCCAG39. The sym-
ol ‘‘1’’ indicates the sense primer, and the symbol ‘‘2’’
ndicates the antisense primer. The template for PCR
as the SmaI-PstI fragment from the 59 flanking region of
he gene (Kuhen and Samuel, 1997). PCR (Saiki et al.,
985) was performed using native Taq DNA polymerase tnd conditions specified by the manufacturer (Perkin–
lmer). Subclones were sequenced to verify base sub-
titutions.
ransfection and reporter assays
For the transient expression assay of Pkr promoter
unction, U cells (60-mm dishes) at a density of ;5 3 105
ells per plate were transfected by the DEAE-dextran-
hloroquine phosphate transfection method (Luthman
nd Magnusson, 1983) using 10 mg of the PKR promoter:
AT reporter gene plasmid and 5 mg of the internal
eference plasmid pRSV2-bgal (generously provided by J.
evins, Durham, NC). For comparative purposes, the
CAT-Control (Promega) plasmid containing the simian
irus 40 promoter and enhancer and the pCAT-Basic
romoter-less plasmid were routinely analyzed in all
ransfection experiments. DNA plasmids used in trans-
ections were purified by cesium chloride equilibrium
entrifugation. Purified plasmids were analyzed by aga-
ose gel electrophoresis to verify plasmid integrity. Treat-
ent with IFN was initiated at ;24 h after transfection.
or analysis of CAT and b-galactosidase activity, cell
ultures were harvested 65 h posttransfection and ex-
racts prepared by repeated freeze-thaw cycles; CAT and
-galactosidase enzyme assays were performed as de-
cribed (Sambrook et al., 1989). The protein concentra-
ion of extracts was determined by the Bradford method
Bio-Rad Laboratories). CAT activity was quantified after
hin layer chromatography by direct measurement of the
4C-acetylated chloramphenicol products using a Beck-
an LS1801 liquid scintillation system to determine the
adioactivity associated with the excised product spots
ocalized using an autoradiogram of the TLC plate. Alter-
atively, the 14C-acetylated chloramphenicol products
ere quantified directly on the TLC plate using a
olecular imager system (Bio-Rad model GS525). CAT
ctivity values, calculated as percentage conversion of
14C]chloramphenicol to the acetylated derivatives, were
ormalized by b-galactosidase activity to control for vari-
tion in transfection efficiency.
ell maintenance and interferon treatment
Human amnion U cells were maintained in Dulbecco’s
odified Eagle’s medium (DMEM) supplemented with
etal bovine serum (Hyclone) at 5% (vol/vol), 100 units of
enicillin per milliliter and 100 mg/ml of streptomycin.
here indicated, interferon treatment was with 1000
U/ml of IFN-/a.
uclear extract preparation
Cells were washed two times with ice-cold phosphate-
uffered saline (PBS) prior to the addition of ice-cold lysis
uffer [STM (20 mM Tris–HC1, pH 7.8; 250 mM sucrose;
.1 mM MgCl2), 0.2% Triton X-100; protease inhibitor cock-
ail (as per Sigma’s recommendation); 50 mM NaF; 1 mM
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194 KUHEN AND SAMUELodium orthovanadate (Na3VO4); and 1 mM phenylmeth-
lsulfonyl fluoride (PMSF)]. Lysates were transferred to
icrofuge tubes and incubated on ice for 5 min. Nuclei
ere separated from the cytoplasm by centrifugation at
4,000 g for 2 min at 4°C. Proteins were extracted from
he nuclear pellet in 100 ml of high salt buffer (STM, 0.4
KCl, 5 mM b-mercaptoethanol, 1 mM PMSF, protease
nhibitors as a cocktail, and phosphatase inhibitors), and
ncubated on ice for 10 min during which time the sample
as mixed vigorously by vortexing every 2 min for 10 s.
uclear extracts were obtained by centrifugation at
4,000 g for 10 min at 4°C. Protein concentration was
etermined by the Bradford method (Bio-Rad). Bandshift
esults were comparable to those obtained using the
xtraction method of Dignam et al. (1983).
ligonucleotide probes
Single-stranded oligodeoxynucleotides were synthe-
ized in-house using a Millipore Cyclone Plus automated
NA synthesizer or were obtained commercially from
peron. The following were used, double-stranded, as
he 32P end-labeled probes or unlabeled competitor oli-
omers in the gel-shift analyses (mutations are indicated
n underlined, boldface type): wild-type KCS, CTGCAGG-
AAGGCGGAGTCCAAGG; wild-type ISRE, CCAAGGG-
AAAACGAAACTGCAG; wild-type KCS/ISRE, CTGCAG
GAAGGCGGAGTCCAAGGGGAAAACGAAACTGCAG;
utant KCS(mt6A), CTGCAGGGAAAGCGGAGTCCAAGG;
utant KCS(mt9T), CTGCAGGGAAGGCTGAGTCCAAGG.
lectrophoretic mobility shift assay
For protein-DNA binding reactions, nuclear extracts
repared from untreated or IFN-treated human U cells
ere incubated (;10 mg of protein) in 25 ml of total
eaction mixture containing 1 mg poly dI:dC; 2 mM Tris,
H 7.6; 0.2 mM EDTA; 8 mM NaCl; 0.8% glycerol; 0.3 mM
-mercaptoethanol; and 5 ng of the 32P-labeled oligonu-
leotide probe. The probe was added last, and the reac-
ion was incubated for 20 min at room temperature. The
ntire reaction mixture was analyzed by gel electro-
horesis, which was carried out using a 5% native poly-
crylamide gel with 0.52 TBE that had been prerun at
°C for 30 min. Electrophoresis was allowed to continue
or ;80 min and the gel was then dried and exposed to
-ray film to obtain an autoradiographic image. Quantifi-
ation of specific gel-shifted complexes was done by
sing a BioRad GS525 molecular imager system.
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ere as described previously (Thomis et al., 1992;anaka and Samuel, 1994; Kuhen and Samuel, 1997). MACKNOWLEDGMENT
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